Source:http://linkedlifedata.com/resource/pubmed/id/16722854
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-5-25
|
pubmed:abstractText |
The study compared the effect of a sustained silver-release foam dressing (Contreet Foam) with a foam dressing (Allevyn Hydrocellular) without added silver in critically colonised venous leg ulcers with delayed healing. The study was a multicentre, open, randomised, controlled study lasting for 4 weeks. Ulcer area and healing were assessed weekly. Odour, maceration, absorption capacity and leakage were evaluated at dressing changes. All adverse events were recorded. One hundred and twenty-nine patients were included (Contreet Foam: 65, Allevyn Hydrocellular: 64). The two groups were comparable in all respects. After 4 weeks, there was a significantly greater reduction in ulcer area in the Contreet Foam group (45%) than in the Allevyn Hydrocellular group (25%). After 1 and 4 weeks, odour was present in significantly less of the ulcers in the Contreet Foam group (17% and 19%, respectively) compared with the Allevyn Hydrocellular group (47% and 39%, respectively) and at the final visit there were significantly fewer leakages in the Contreet Foam group (19%) compared with the Allevyn Hydrocellular group (49%). Also, less maceration was observed after 1 and 4 weeks in the Contreet Foam group (34% and 37%, respectively) compared with the Allevyn Hydrocellular group (55% and 48%, respectively). The occurrence and cause of adverse events were equally distributed between the study groups. The present study provides evidence of the superior performance of the silver-releasing dressing, Contreet Foam, compared with a traditional moist foam wound healing dressing in the treatment of critically colonised, chronic venous leg ulcers. The results of this randomised, controlled study suggest an important role of sustained silver-releasing dressings in the treatment of critically colonised chronic wounds.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1742-4801
|
pubmed:author |
pubmed-author:AgerslevRikke HRH,
pubmed-author:AndersenKlaus EKE,
pubmed-author:Bech-ThomsenNielsN,
pubmed-author:BendzSusanne HSH,
pubmed-author:CoerperStefanS,
pubmed-author:GottrupFinnF,
pubmed-author:JørgensenBoB,
pubmed-author:JemecGregorG,
pubmed-author:KirsnerRobertR,
pubmed-author:LarsenJan RJR,
pubmed-author:LeaperDavid JDJ,
pubmed-author:NeumannMartino HaMH,
pubmed-author:PricePatriciaP,
pubmed-author:RheinenHenrietteH,
pubmed-author:Roed-PetersenJytteJ,
pubmed-author:RomanelliMarcoM,
pubmed-author:ScanlonElizabethE,
pubmed-author:SibbaldR GaryRG,
pubmed-author:VeraartJoepJ
|
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
64-73
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16722854-Adult,
pubmed-meshheading:16722854-Aged,
pubmed-meshheading:16722854-Aged, 80 and over,
pubmed-meshheading:16722854-Bandages, Hydrocolloid,
pubmed-meshheading:16722854-Delayed-Action Preparations,
pubmed-meshheading:16722854-Female,
pubmed-meshheading:16722854-Follow-Up Studies,
pubmed-meshheading:16722854-Humans,
pubmed-meshheading:16722854-Male,
pubmed-meshheading:16722854-Middle Aged,
pubmed-meshheading:16722854-Polyurethanes,
pubmed-meshheading:16722854-Quality of Life,
pubmed-meshheading:16722854-Silver Compounds,
pubmed-meshheading:16722854-Treatment Outcome,
pubmed-meshheading:16722854-Varicose Ulcer,
pubmed-meshheading:16722854-Wound Healing,
pubmed-meshheading:16722854-Wound Infection
|
pubmed:year |
2005
|
pubmed:articleTitle |
The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial.
|
pubmed:affiliation |
Copenhagen Wound Healing Centre, Bispebjerg University Hospital, Copenhagen, Denmark.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|